α‐Synuclein Inclusions in Amygdala in the Brains of Patients with the Parkinsonism‐Dementia Complex of Guam

We investigated by immunohistochemistry the deposition of α-synuclein in the brains of deceased patients with the parkinsonism-dementia complex (PDC) of Guam. Five of 13 PDC brains showed numerous α-synuclein positive neuronal inclusions and abnormal neurites, chiefly in the amygdala. Similar α-synuclein positive lesions were observed, although to a lesser extent, in the entorhinal cortex and the dorsal vagal nucleus. No α-synuclein positive inclusions were observed in motor cortex or locus coeruleus, and only a small number of positive inclusions were found in the Sommer's sector, temporal cortex, or substantia nigra. Some of the α-synuclein positive inclusions were reminiscent of cortical Lewy bodies (LB), but many of those in the amygdala coexisted with tau-positive pretangles and/or neurofibrillary tangles (NFT) within the same neurons. In these neurons, tau-positive shells encapsulated α-synuclein positive central cores or irregularly shaped α-synuclein-positive deposition intermingled with pretangles/NFT. Thus, the present study suggests that a common mechanism may govern aggregation of α-synuclein and tau in the amygdala, and that aggregation of α-synuclein may play some role in the neurodegenerative process of a tauopathy (i.e. PDC) in which Aβ deposition is virtually absent.

[1]  D. Dickson,et al.  Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease , 1991, Neurology.

[2]  J Q Trojanowski,et al.  Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes. , 1998, The American journal of pathology.

[3]  R. Garruto,et al.  Disappearance of high‐incidence amyotrophic lateral sclerosis and parkinsonism‐dementia on Guam , 1985, Neurology.

[4]  Hitoshi Takahashi,et al.  α-Synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy , 1998, Neuroscience Letters.

[5]  T. Iwaki,et al.  Hydrated autoclave pretreatment enhances tau immunoreactivity in formalin-fixed normal and Alzheimer's disease brain tissues. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[6]  R. Garruto,et al.  Amyotrophic lateral sclerosis and parkinsonism‐dementia among Filipino migrants to Guam , 1981, Annals of neurology.

[7]  Hitoshi Takahashi,et al.  NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease , 1997, Neuroscience Letters.

[8]  J. Trojanowski,et al.  Epitope mapping of LB509, a monoclonal antibody directed against human α-synuclein , 1999, Neuroscience Letters.

[9]  J Q Trojanowski,et al.  Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. , 1998, The American journal of pathology.

[10]  T. Chase,et al.  Distinct Pathological Features of the Gallyas‐ and Tau‐positive Glia in the Parkinsonism‐Dementia Complex and Amyotrophic Lateral Sclerosis of Guam , 1997, Journal of neuropathology and experimental neurology.

[11]  Hitoshi Takahashi,et al.  Accumulation of α-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy , 1998, Acta Neuropathologica.

[12]  John A. Martin,et al.  Convergence of Lewy bodies and neurofibrillary tangles in amygdala neurons of Alzheimer’s disease and Lewy body disorders , 1996, Acta Neuropathologica.

[13]  S. Shankar,et al.  Immunocytochemical characterization of neurofibrillary tangles in amyotrophic lateral sclerosis and parkinsonism‐dementia of guam , 1989, Annals of neurology.

[14]  L. Kurland,et al.  Parkinsonism-dementia complex, an endemic disease on the island of Guam. II. Pathological features. , 1961, Brain : a journal of neurology.

[15]  B. Hyman,et al.  Nigral and Cortical Lewy Bodies and Dystrophic Nigral Neurites in Parkinson's Disease and Cortical Lewy Body Disease Contain α-synuclein Immunoreactivity , 1998, Journal of neuropathology and experimental neurology.

[16]  J Q Trojanowski,et al.  Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α‐synuclein , 1998, Annals of neurology.

[17]  S. Tsuji,et al.  Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. , 1998, Neuroscience letters.

[18]  T. Iwatsubo,et al.  Juvenile-onset generalized neuroaxonal dystrophy (Hallervorden-Spatz disease) with diffuse neurofibrillary and Lewy body pathology , 2000, Acta Neuropathologica.

[19]  Akihiko Iwai,et al.  The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system , 1995, Neuron.

[20]  M. L. Schmidt,et al.  α-Synuclein in Lewy bodies , 1997, Nature.

[21]  Peter T. Lansbury,et al.  Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease , 1998, Nature Medicine.

[22]  P. Hof,et al.  Neurofibrillary degeneration in amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam. Immunochemical characterization of tau proteins. , 1995, The American journal of pathology.

[23]  S. Nakajo,et al.  A new brain-specific 14-kDa protein is a phosphoprotein. Its complete amino acid sequence and evidence for phosphorylation. , 1993, European journal of biochemistry.

[24]  M. Yoshida,et al.  A 14-year-old patient with Ewing's sarcoma presenting at autopsy with multiple neurofibrillary tangles and Lewy bodies in addition to hemiatrophy of the central nervous system. , 1997, Clinical neuropathology.

[25]  D. Perl,et al.  Adult onset Hallervorden-Spatz disease with neurofibrillary pathology. A discrete clinicopathological entity. , 1987, Brain : a journal of neurology.

[26]  J. Trojanowski,et al.  Antibodies to α‐synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease , 1999, Annals of neurology.

[27]  S. Nakajo,et al.  Cell and tissue distribution and developmental change of neuron specific 14 kDa protein (phosphoneuroprotein 14) , 1993, Brain Research.

[28]  L. Kurland,et al.  Parkinsonism-dementia complex, an endemic disease on the island of Guam. I. Clinical features. , 1961, Brain : a journal of neurology.

[29]  J. Hardy,et al.  Neurodegenerative diseases of Guam: Analysis of TAU , 1999, Neurology.

[30]  E. Masliah,et al.  Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[31]  T. Aiuchi,et al.  Purification and Characterization of a Novel Brain‐Specific 14‐kDa Protein , 1990, Journal of neurochemistry.

[32]  S. Nakajo,et al.  Distribution of phosphoneuroprotein 14 (PNP 14) in vertebrates: its levels as determined by enzyme immunoassay , 1996, Brain Research.